Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Atazanavir/Cobicistat and Microgynon 30 in Healthy Women
NCT02697851Phase 1Terminated
- Sponsor
- St Stephen's AIDS Trust
- Start
- Jul 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atazanavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by St Stephen's AIDS Trust. Primary endpoints: Trough Plasma Concentration at Day 56, Peak Plasma Concentration at Day 56 and 3 more. Started Jul 2016; status: terminated.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02697851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697851.